Transactions

Desitin Arzneimittel GmbH licensed US rights to Oxcarbazepine MR to Jazz Pharmaceuticals

Jul. 2005

Client: Desitin Arzneimittel GmbH is a leading developer and marketer in selected European countries of central nervous system (CNS) prescription pharmaceuticals

Role: Edgemont Partners acted as exclusive financial advisor to Desitin Arzneimittel GmbH in its partnering of exclusive U.S. rights to its development stage product Oxcarbazepine MR to Jazz Pharmaceuticals

Location: Hamburg, Germany

Sector: Pharmaceutical Services

View Press Release Connect with Lead Banker

desitin arzneimittel gmbh logo

licensed US rights to Oxcarbazepine MR to

jazz pharmaceuticals logo
Get In Touch